Bacterial expression of a neutralizing mouse monoclonal antibody Fab fragment to a 150-kilodalton surface antigen of Entamoeba histolytica

American Journal of Tropical Medicine and Hygiene

Volumn 60, Issue 1, 1999, Pages 35-40

  Tachibana, Hiroshi ^a   Takekoshi, Masataka ^a   Cheng, Xun Jia ^a   Maeda, Fumiko ^a   Aotsuka, Satoshi ^b   Ihara, Seiji ^a  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Nisshinbo Industries Inc   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HISTIDINE; IMMUNOGLOBULIN F(AB) FRAGMENT; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN LIGHT CHAIN; MEMBRANE ANTIGEN; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; PARASITE ANTIGEN; RECOMBINANT PROTEIN;

ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; ENTAMOEBA HISTOLYTICA; ERYTHROCYTE; ESCHERICHIA COLI; GENE EXPRESSION SYSTEM; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOFLUORESCENCE TEST; MOUSE; NONHUMAN;

BACTERIA (MICROORGANISMS); ENTAMOEBA HISTOLYTICA; ESCHERICHIA COLI; MAMMALIA; NEGIBACTERIA; PROTOZOA;

EID: 0032952977     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.1999.60.1.9988319     Document Type: Article

References (43)

1. Walsh JA, 1988. Prevalence of Entamoeba histolytica infection. Ravdin JI, ed. Amebiasis. Human infection by Entamoeba histolytica. New York: John Wiley & Sons, 93-105.
2. Ghadirian E, Meerovitch E, 1978. Vaccination against hepatic amebiasis in hamsters. J Parasitol 64: 742-743.
3. Ghadirian E, Meerovitch E, Hartmann DP, 1980. Protection against amebic liver abscess in hamsters by means of immunization with amebic antigen and some of its fractions. Am J Trop Med Hyg 29: 779-784.
4. Nain PCK, Vinayak VK, 1987. Elicitation of protective immunity to Entamoeba histolytica - an experimental study. Immunol Cell Biol 65: 217-222.
5. Petri WA Jr, Ravdin JI, 1991. Protection of gerbils from amebic liver abscess by immunization with the galactose-specific adherence lectin of Entamoeba histolytica. Infect Immun 59: 97-101.
6. Ravdin JI, Shain DC, Kelsall BL, 1993. Antigenicity, immunogenicity and vaccine efficacy of the galactose-specific adherence protein of Entamoeba histolytica. Vaccine 11: 241-246.
7. Zhang T, Cieslak PR, Stanley SL Jr, 1994. Protection of gerbils from amebic liver abscess by immunization with a recombinant Entamoeba histolytica antigen. Infect Immun 62: 1166-1170.
8. Zhang T, Stanley SL Jr, 1994. Protection of gerbils from amebic liver abscess by immunization with a recombinant protein derived from the 170-kilodalton surface adhesin of Entamoeba histolytica. Infect Immun 62: 2605-2608.
9. Soong CJG, Kain KC, Abd-Alla M, Jackson TFHG, Ravdin JI, 1995. A recombinant cysteine-rich section of the Entamoeba histolytica galactose-inhibitable lectin is efficacious as a subunit vaccine in the gerbil model of amebic liver abscess. J infect Dis 171: 645-651.
10. Zhang T, Cieslak PR, Foster L, Kunz-Jenkins C, Stanley SL Jr, 1994. Antibodies to the serine rich Entamoeba histolytica protein (SREHP) prevent amoebic liver abscess in severe combined immunodeficient (SCID) mice. Parasite Immunol 16: 225-230.
11. Seydel KB, Braun KL, Zhang T, Jackson TFHG, Stanley SL Jr, 1996. Protection against amebic liver abscess formation in the severe combined immunodeficient mouse by human antiamebic antibodies. Am J Trop Med Hyg 55: 330-332.
12. Barbas CF, Kang AS, Lerner RA, Benkovic SJ, 1991. Assembly of combinatorial antibody libraries on phage surfaces: the gene III site. Proc Natl Acad Sci USA 88: 7978-7982.
13. Burton DR, Barbas CF, Persson MAA, Koenig S, Chanock RM, Lerner RA, 1991. A large array of human monoclonal antibodies to type 1 human immunodeficiency virus from combinatorial libraries of asymptomatic seropositive individuals. Proc Natl Acad Sci USA 88: 10134-10137.
14. Zebedee SL, Barbas CF, Hom YL, Caothien RH, Graff R, DeGraw J, Pyati J, LaPolla R, Burton DR, Lerner RA, Thornton GB, 1992. Human combinatorial antibody libraries to hepatitis B surface antigen. Proc Natl Acad Sci USA 89: 3175-3179.
15. Barbas CF, Björling E, Chiodi F, Dunlop N, Cababa D, Jones TM, Zebedee SL, Persson MAA, Nara PL, Norrby E, Burton DR, 1992. Recombinant human Fab fragments neutralize human type 1 immunodeficiency virus in vitro. Proc Natl Acad Sci USA 89: 9339-9343.
16. Barbas CF, Crowe JE, Cababa D, Jones TM, Zebedee SL, Murphy BR, Chanock RM, Burton DR, 1992. Human monoclonal Fab fragments derived from a combinatorial library bind to respiratory syncytial virus F glycoprotein and neutralize infectivity. Proc Natl Acad Sci USA 89: 10164-10168.
17. Burioni R, Williamson RA, Sanna PP, Bloom FE, Burton DR, 1994. Recombinant human Fab to glycoprotein D neutralizes infcctivity and prevents cell-to-cell transmission of herpes simplex viruses 1 and 2 in vitro. Proc Natl Acad Sci USA 91: 355-359.
18. Barbas CF, Hu D, Dunlop N, Sawyer L, Cababa D, Hendry RM, Nara PL, Burton DR, 1994. In vitro evolution of a neutralizing human antibody to human immunodeficiency virus type 1 to enhance affinity and broaden strain crossreactivity. Proc Natl Acad Sci USA 91: 3809-3813.
19. Takekoshi M, Maeda F, Tachibana H, Inoko H, Kato S, Takakura I, Kenjyo T, Hiraga S, Ogawa Y, Horiki T, Ihara S, 1998. Human monoclonal anti-HCMV neutralizing antibody from phage display libraries. J Virol Methods 74: 89-98.
20. Tachibana H, Kobayashi S, Cheng XJ, Hiwatashi E, 1997. Differentiation of Entamoeba histolytic from E. dispar facilitated by monoclonal antibodies against a 150-kDa surface antigen. Parasitol Res 83: 435-439.
21. Cheng XJ, Tsukamoto H, Kaneda Y, Tachibana H, 1998. Identification of the 150-kDa surface antigen of Entamoeba histolytica as a galactose-and N-acetyl-D-galactosamine-inhibitable lectin. Parasitol Res 84: 632-639.
22. Cheng XJ, Kaneda Y, Tachibana H, 1997. A monoclonal antibody against the 150-kDa surface antigen of Entamoeba histolytica inhibits adherence and cytotoxicity to mammalian cells. Med Sci Res 25: 159-161.
23. Diamond LS, Harlow DR, Cunnick CC, 1978. A new medium for the axenic cultivation of Entamoeba histolytica and other Entamoeba. Trans R Soc Trop Med Hyg 72: 431-432.
24. Takeuchi T, Kobayashi S, 1997. Entamoeba dispar: cultivation without viable associate and its characterization. Arch Med Res 28: S108-S109.
25. Tachibana H, Kobayashi S, Kato Y, Nagakura K, Kaneda Y, Takeuchi T, 1990. Identification of a pathogenic isolate-specific 30,000-Mr antigen of Entamoeba histolytica by using a monoclonal antibody. Infect Immun 58: 955-960.
26. Tachibana H, Kobayashi S, Nagakura K, Kaneda Y, Takeuchi T, 1991. Reactivity of monoclonal antibodies to species-specific antigens of Entamoeba histolytica. J Protozool 38: 329-334.
27. Laemmli UK, 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685.
28. Towbin H, Staehelin T, Gordon J, 1979. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 76: 4350-4354.
29. Trissl D, Martínez-Palomo A, de la Torre M, de la Hoz R, de Suárez EP, 1978. Surface properties of Entamoeba: increased rates of human erythrocyte phagocytosis in pathogenic strains. J Exp Med 148: 1137-1145.
30. Skerra A, Plückthun A, 1988. Assembly of a functional immunoglobulin Fv fragment in Escherichia coli. Science 240: 1038-1041.
31. Better M, Chang CP, Robinson RR, Horwitz AH, 1988. Escherichia coli secretion of an active chimeric antibody fragment. Science 240: 1041-1043.
32. Condra JH, Sardana VV, Tomassini JE, Schlabach AJ, Davies ME, Lineberger DW, Graham DJ, Gotlib L, Colonno RJ, 1990. Bacterial expression of antibody fragments that block human rhinovirus infection of cultured cells. J Biol Chem 265: 2292-2295.
33. Skerra A, Pfitzinger I, Plückthun A, 1991. The functional expression of antibody Fv fragments in Escherichia coli: improved vectors and a generally applicable purification technique. Bio/Technology 9: 273-278.
34. Alfthan K, Takkinen K, Sizmann D, Seppälä I, Immonen T, Vanne L, Keränen S, Kaartinen M, Knowles JKC, Teeri TT, 1993. Efficient secretion of murine Fab fragments by Escherichia coli is determined by the first constant domain of the heavy chain. Gene 128: 203-209.
35. Kipp B, Schlaak M, Becker WM, 1996. Cloning and expression of a murine Fab fragment recognizing a defined linear epitope of Chironomus thummi thummi major allergen Chi t 1-9. Int Arch Allergy Immunol 110: 348-353.
36. Liang M, Chu YK, Schmaljohn C, 1996. Bacterial expression of neutralizing mouse monoclonal antibody Fab fragments to Hantaan virus. Virology 217: 262-271.
37. Strachan WD, Chiodini PL, Spice WM, Moody AH, Ackers JP, 1988. Immunological differentiation of pathogenic and nonpathogenic isolates of Entamoeba histolytica. Lancet i: 561-563.
38. Petri WA Jr, Jackson TFHG, Gathiram V, Kress K, Saffer LD, Snodgrass TL, Chapman MD, Keren Z, Mirelman D, 1990. Pathogenic and nonpathogenic strains of Entamoeba histolytica can be differentiated by monoclonal antibodies to the galactose-specific adherence lectin. Infect Immun 58: 1802-1806.
39. Gonzalez-Ruiz A, Haque R, Rehman T, Aguirre A, Jaramillo C, Castañon G, Hall A, Guhl F, Ruiz-Palacios G, Warhurst DC, Miles MA, 1992. A monoclonal antibody for distinction of invasive and noninvasive clinical isolates of Entamoeba histolytica. J Clin Microbiol 30: 2807-2813.
40. Haque R, Kress K, Wood S, Jackson TFHG, Lyerly D, Wilkins T, Petri WA Jr, 1993. Diagnosis of pathogenic Entamoeba histolytica infection using a stool ELISA based on monoclonal antibodies to the galactose-specific adhesin. J Infect Dis 167: 247-249.
41. Abd-Alla MD, Jackson TFHG, Gathiram V, El-Hawey AM, Ravdin JI, 1993. Differentiation of pathogenic Entamoeba histolytica infections from nonpathogenic infections by detection of galactose-inhibitable adherence protein antigen in sera and feces. J Clin Microbiol 31: 2845-2850.
42. Tachibana H, Kobayashi S, Kaneda Y, Takeuchi T, Fujiwara T, 1997. Preparation of a monoclonal antibody specific for Entamoeba dispar and its ability to distinguish E. dispar from E. histolytica. Clin Diagn Lab Immunol 4: 409-414.
43. Skerra A, 1994. A general vector, pASK84, for cloning, bacterial production, and single-step purification of antibody Fab fragments. Gene 141: 79-84.